SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C - Offering Statement:
SEC Accession No. 0001669191-19-000377
Filing Date
2019-10-22
Accepted
2019-10-22 08:29:25
Documents
14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9784
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 137737
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1951575
4 INCOME STATEMENT income.pdf EX-99 122601
5 BALANCE SHEET balancesheet.pdf EX-99 249199
6 CASH FLOW STATEMENT cashflow.pdf EX-99 396022
7 CHANGE IN EQUITY STATEMENT changeinequity.pdf EX-99 220874
8 CPA AUDIT REPORT auditreport.pdf EX-99 298508
9 PRINCIPAL EXECUTIVE CERTIFICATION executivecertification.pdf EX-99 60018
10 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 12718331
11 CORPORATE BYLAWS corporatebylaws.pdf EX-99 95547
12 PITCH DECK pitchdeck.pdf EX-99 1167610
13 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
14 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 245
  Complete submission text file 0001669191-19-000377.txt   24183401
Mailing Address 16776 BERNARDO CENTER DRIVE, SUITE 203 SAN DIEGO CA 92128
Business Address 16776 BERNARDO CENTER DRIVE, SUITE 203 SAN DIEGO CA 92128 8584516173
Global Cancer Technology, Inc. (Filer) CIK: 0001743261 (see all company filings)

IRS No.: 461785241 | State of Incorp.: NV | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-25769 | Film No.: 191160617
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences